Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Epinephrin, ATC C01CA24 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Epinephrin, ATC C01CA24 für die Zeit 01.07.2025…”. Bids close on 5 May 2028. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount agreement for the active substance Epinephrine (ATC C01CA24) for the period 01.07.2025 - 30.06.2027, with an option for one 12-month extension.
- Agreement must be for Epinephrine (ATC C01CA24) exclusively in injectable forms.
- Contract must be submitted electronically via email.
- Submission deadline is the 5th of the preceding month for the desired contract start date.
Key facts
- Contract period
- 01.07.2025 - 30.06.2027 (with a 1x12 month extension option)
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- Siehe Antragsschreiben.
Experience
- At least 1 similar work — Experience with pharmaceutical discount agreements for Epinephrine (ATC C01CA24) is implied by the context of the tender.
- Experience with pharmaceutical discount agreements for Epinephrine (ATC C01CA24).
Certifications and registrations
ISO 9001 (optional)Not mentioned in the provided text.
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenCover letter as part of the application.
- Vertrag mit Namen oder FirmenstempelAcknowledgment of contractual terms, including specified discounts.
- Anlage 1 zum VertragFilled-out contract annex 1.
- Anlage 2 zum VertragFilled-out contract annex 2, specifying the drugs (must be in Excel format).